Centenial Surgical Suture Ltd
BSE:531380
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Centenial Surgical Suture Ltd
Cash from Operating Activities
Centenial Surgical Suture Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Centenial Surgical Suture Ltd
BSE:531380
|
Cash from Operating Activities
₹170.7m
|
CAGR 3-Years
53%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
|
G
|
GKB Ophthalmics Ltd
BSE:533212
|
Cash from Operating Activities
-₹27.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Poly Medicure Ltd
NSE:POLYMED
|
Cash from Operating Activities
₹2.7B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
PREVEST DENPRO LTD
BSE:543363
|
Cash from Operating Activities
₹148.2m
|
CAGR 3-Years
29%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Laxmi Dental Ltd
NSE:LAXMIDENTL
|
Cash from Operating Activities
₹438.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
GSM Foils Ltd
NSE:GSMFOILS
|
Cash from Operating Activities
-₹176.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centenial Surgical Suture Ltd
Glance View
Centenial Surgical Suture Ltd. is a medical device company, which engages in the manufacturing of surgical sutures and medical devices. The company is headquartered in Thane, Maharashtra. The company went IPO on 2005-09-16. The firm operates through the Medical Devices segment. The firm's products include atraumatic needles and sutures (absorbable and non-absorbable) and cardio blades. Its absorbable sutures consist of natural sutures and synthetic sutures, where natural sutures include Centenial-Catgut Plain, and Centenial-Catgut Chromic, and synthetic sutures include Centicryl Braided, Centicryl Rapid, Monosynth and Centisorb. Its non-absorbable sutures include Centilene, Centlon, Centsilk, Centibond, Centsteel and Centipace. Its medical devices include T-SUIT, Centilene Mesh, Skin Stapler, Centiclip, Aortic Punch and Kinfe. The company supplies technical specifications, including tables of dimensions and strength values, as well as chemicals and dye stuffs used in manufacturing each suture material.
See Also
What is Centenial Surgical Suture Ltd's Cash from Operating Activities?
Cash from Operating Activities
170.7m
INR
Based on the financial report for Mar 31, 2025, Centenial Surgical Suture Ltd's Cash from Operating Activities amounts to 170.7m INR.
What is Centenial Surgical Suture Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
52%
Over the last year, the Cash from Operating Activities growth was 175%. The average annual Cash from Operating Activities growth rates for Centenial Surgical Suture Ltd have been 53% over the past three years , 52% over the past five years .
